Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Serrone L and Hersey P (1999) Melanoma Res. 9: 51–58
Soengas MS et al. (2001) Nature 409: 207–211
Brown JM and Wouters BG (1999) Cancer Res. 59: 1391–1399
Baldi A et al. (2004) Exp. Dematol. 13: 93–97
Fujimoto A et al. (2004) Cancer Res. 64: 2245–2250
Scott CL et al. (2004) J. Cell. Biol. 164: 89–96
Marsden VS et al. (2002) Nature 419: 634–637
Zanon M et al. (2004) Cancer Res. 64: 7386–7394
Svingen PA et al. (2004) Clin. Cancer Res. 10: 6807–6820
Hofer-Warbinek R et al. (2004) Cell Death Differ. 11: 1317–1325
Kaufman SH and Vaux DL (2003) Oncogene 22: 7414–7430
Huang DC and Strasser A (2000) Cell 103: 839–842
Hausmann G et al. (2000) J. Cell. Biol. 149: 623–634
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Cell Death and Differentiation website (http://www.nature.com/cdd)
Supplementary information
Rights and permissions
About this article
Cite this article
Allen, J., Zhang, X., Scott, C. et al. Is Apaf-1 expression frequently abrogated in melanoma?. Cell Death Differ 12, 680–681 (2005). https://doi.org/10.1038/sj.cdd.4401634
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.cdd.4401634
This article is cited by
-
Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis
Oncogene (2008)
-
BH3-only proteins in cell death initiation, malignant disease and anticancer therapy
Cell Death & Differentiation (2006)
